Bayer achieves 98.3% take-up for rights issue
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Equity

Bayer achieves 98.3% take-up for rights issue

Bayer 230x150

Bayer, the German pharmaceuticals giant, has completed its jumbo €6bn rights issue with 98.3% of shareholders taking up their rights.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article